<DOC>
	<DOCNO>NCT02325401</DOCNO>
	<brief_summary>The purpose research study test safety add metformin standard care . The standard care treatment cisplatin every 3 week 3 treatment radiation 7 week . Metformin medication currently use treat diabetes . Increasing amount metformin give group patient already receive normal treatment cancer see metformin cause good effect kill cancer bad effect ( side effect ) .</brief_summary>
	<brief_title>Dose-finding Study Metformin With Chemoradiation Locally Advanced Head Neck Squamous Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Locally advanced squamous cell cancer head neck , stage III IV disease ( T12 , N2a3 T34 ) . Measurable disease No prior chemotherapy radiation head neck squamous cell cancer Life expectancy great 3 month . Adequate labs Known metastatic disease . Nasopharyngeal carcinoma History allergic reaction attribute metformin agent use study . Known diagnosis diabetes require insulin control . Administration metformin within last 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>